Medtronic Plc. (MDT) reported strong
financial results for the second quarter of fiscal 2026, indicating
accelerated momentum due to its
enterprise growth drivers. Some influential figures, including
Jim Cramer and analysts at
Goldman Sachs, have shared positive sentiments about the company. However, firms like
Franklin Resources Inc. and
Westfield Capital Management Co. LP have reduced their stock holdings in Medtronic. The firm reports a strong performance, including increased holdings by the
Swiss National Bank and purchases by
Raiffeisen Bank International AG. Nevertheless, some entities pointed out weak financial prospects dragging down Medtronic's stock. The firm has
boosted its FY26 outlook following noteworthy Q2 earnings.
Goldman Sachs raised the price target for Medtronic on account of its promising FY26 outlook. Despite these successes,
some analysts believe that the company's growth story needs further reinvigoration.
Medtronic Plc MDT News Analytics from Tue, 05 Aug 2025 07:00:00 GMT to Sat, 22 Nov 2025 17:12:29 GMT -
Rating 5
- Innovation 7
- Information 8
- Rumor -4
